C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2009
03/19/2009	US20090074870 Alteration of cell membrane for new functions
03/19/2009	US20090074864 Novel antimicrobial peptides with heparin binding activity
03/19/2009	US20090074843 Use of epi-hne 1-4
03/19/2009	US20090074830 Anti-angiogenic compositions and methods of use
03/19/2009	US20090074817 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
03/19/2009	US20090074813 Compositions And Methods Using Variant Tat Proteins
03/19/2009	US20090074808 Secreted Streptococcus Pneumoniae Proteins
03/19/2009	US20090074807 Moraxella (branhamella) catarrhalis antigens
03/19/2009	US20090074806 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
03/19/2009	US20090074804 Vero cell-based influenza virus strains and vaccines
03/19/2009	US20090074801 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen phl p 7
03/19/2009	US20090074800 Cancer antigen and use thereof
03/19/2009	US20090074799 Antibodies to class ii cytokine receptor-7
03/19/2009	US20090074797 useful in the management of various cancers which express 20P2H8, particularly including cancers of the bladder, prostate, colon and pancreas
03/19/2009	US20090074784 Treatment of chronic viral diseases with antibodies to costimulating polypeptide of T cells
03/19/2009	US20090074783 isolated and purified protein produced by a naturally occurring Babesia sp. and an isolated and purified nucleic acid encoding the above protein; use in diagnosing and treating a mammal infected with a Babesia sp.
03/19/2009	US20090074782 Compositions and Methods for Treating and Diagnosing Cancer
03/19/2009	US20090074781 Dengue virus peptide vaccine and methods of preparing and using the same
03/19/2009	US20090074779 Neurotrophin-derived peptide sequences
03/19/2009	US20090074778 human monoclonal or polyclonal antibodies or fragments, that specifically binds to proteins in a blot analysis or enzyme-linked immunosorbent assay; detection of proteins in biological samples
03/19/2009	US20090074776 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence
03/19/2009	US20090074774 Fgfr binding peptides
03/19/2009	US20090074773 Cancer vaccine
03/19/2009	US20090074770 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof
03/19/2009	US20090074769 Glp-1 analog fusion proteins
03/19/2009	US20090074756 Use of llt1 and/or cd161 for modulatting the activity of cells of the immune system
03/19/2009	US20090074755 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections
03/19/2009	US20090074742 Protein, osteoclast differentiation inhibitor, inflammatory bone resorption therapeutic agent, gene, recombinant vector, method of manufacturing a protein, method of inhibiting osteoclast differentiation, and method of treating inflammatory bone resorption
03/19/2009	US20090074730 Novel stem cells, nucleotide sequences and proteins therefrom
03/19/2009	US20090074726 Mva expressing modified hiv envelope, gag, and pol genes
03/19/2009	US20090074724 Materials and methods for inhibiting wip1
03/19/2009	US20090074723 Method of Treating or Retarding the Development of Blindness
03/19/2009	US20090074718 Avian derived erythropoietin
03/19/2009	US20090074694 Dyed-hair-binding peptides and peptide-based hair reagents for personal care
03/19/2009	US20090074680 Statherin peptide and use in medicine
03/19/2009	US20090074666 Peptide vaccine for influenza virus
03/19/2009	US20090074665 Diagnosis and treatment of cancer:I
03/19/2009	US20090074661 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
03/19/2009	US20090074657 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof
03/19/2009	US20090070944 Hair binding peptides and peptide-based hair reagents for personal care
03/19/2009	DE102007044673A1 Impfstoff zur Behandlung von Zöliakie und Verfahren zur Herstellung des Impfstoffes, Verwendung einer mit einem bakteriellen Toxin konjugierten Peptidsequenz zur Aktivierung des Immunsystems gegen Prolamine sowie Designerpeptid Vaccine for the treatment of celiac disease and method of producing the vaccine, Use of a conjugated with a bacterial toxin peptide sequence for activating the immune system against prolamines and Designer peptide
03/19/2009	DE102007041862A1 Mikrobiologische Herstellung von Isoprenoiden Microbiological production of isoprenoids
03/19/2009	CA2737126A1 Novel p2x7 epitopes
03/19/2009	CA2699794A1 Mitochondria-targeted anti-tumour agents
03/19/2009	CA2699467A1 Peptide sequences and compositions
03/19/2009	CA2699465A1 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use
03/19/2009	CA2699435A1 Pharmaceutical compositions containing clostridium difficile toxoids a and b
03/19/2009	CA2699429A1 Recombinant preparation of selected bromelain fractions
03/19/2009	CA2699225A1 Streptococcus pneumoniae vaccines
03/19/2009	CA2699093A1 Malva mosaic virus and virus-like particles and uses thereof
03/19/2009	CA2698990A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects
03/19/2009	CA2698801A1 Molecule production by photosynthetic organisms
03/19/2009	CA2696987A1 Hepatitis b pre-s2 nucleic acid
03/18/2009	EP2036982A1 Pesticidal proteins
03/18/2009	EP2036978A1 Recombinant preparation of selected bromelain fractions
03/18/2009	EP2036925A1 Novel steroid-activated nuclear receptors and uses therefor
03/18/2009	EP2036924A2 Gene regulatory peptides
03/18/2009	EP2036923A1 Improved derivates of amylin
03/18/2009	EP2036922A1 Novel antihypertensive peptide and use thereof
03/18/2009	EP2036921A1 Use of Slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases
03/18/2009	EP2036573A1 HLA binding peptides and their uses
03/18/2009	EP2036569A2 Method for Treating Secondary Immunodeficiency
03/18/2009	EP2035827A1 Nucleic acid, polypeptide and its use
03/18/2009	EP2035566A2 Materials and complexes for the delivery of biologically-active material to cells
03/18/2009	EP2035564A2 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
03/18/2009	EP2035563A2 Pathogen-inducible synthetic promoter
03/18/2009	EP2035562A2 Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same
03/18/2009	EP2035559A2 Methods and compositions related to bacterial flagellum and nanotube formation
03/18/2009	EP2035556A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
03/18/2009	EP2035453A2 Cd4 mimic peptides and their uses
03/18/2009	EP2035451A1 Insulinotropic peptide synthesis
03/18/2009	EP2035450A2 Composition and methods for treatment of congestive heart failure
03/18/2009	EP2035449A2 Methods of identifying insect-specific spider toxin mimics
03/18/2009	EP2035448A2 Neuroactive fragments of app
03/18/2009	EP2035447A2 Polypeptide
03/18/2009	EP2035446A2 Ribozyme mediated stabilization of polynucleotides
03/18/2009	EP2035035A2 Immunogenic compositions for streptococcus agalactiae
03/18/2009	EP1987144A4 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh
03/18/2009	EP1869081A4 POP2 NFkB-INHIBITING POLYPEPTIDES, NUCLEIC ACIDS AND METHODS OF USE
03/18/2009	EP1620129B1 Cyanovirin variant-polymer conjugates
03/18/2009	EP1565579B1 Methods for identifying risk of breast cancer
03/18/2009	EP1517918B1 Peptides having affinity for a phospholipid and uses
03/18/2009	EP1515745B1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
03/18/2009	EP1463942B1 Methods for purifying protein
03/18/2009	EP1462112B1 Remedies for dry eye and diseases associated with dry eye
03/18/2009	EP1399499B1 Agent for the prevention and treatment of sexually transmitted diseases-i
03/18/2009	EP1399482B1 Determination of bone-sialoprotein in bodily fluids for oncological problems
03/18/2009	EP1386167B1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
03/18/2009	EP1343815B1 Antibacterial treatments
03/18/2009	EP1283887B1 Chimeric arterivirus-like particles
03/18/2009	EP1200612B1 Dna encoding a plant deoxyhypusine synthase, transgenic plants and a method for controlling senescence and programmed cell death in plants
03/18/2009	EP1189937B1 Purified antigen for alzheimer's disease, and methods of obtaining and using same
03/18/2009	EP1185288A4 Hemoactive compositions and methods for their manufacture and use
03/18/2009	EP1137791B1 Regulatory sequences of the mouse villin gene - use in transgenesis
03/18/2009	EP1068522B1 Helicobacter pylori nap protein
03/18/2009	EP1019714B1 Diagnosis of williams syndrome and williams syndrome cognitive profile by analysis of the presence or absence of a lim-kinase gene
03/18/2009	EP0975954B2 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
03/18/2009	EP0814834B2 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same
03/18/2009	EP0741783B1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
03/18/2009	EP0732937B2 Non-toxic mucosal adjuvant

1 ... 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 ... 2916